Meeting
2023 ASCO Annual Meeting
SWOG S1823/CCTG GCC1: Translational observational investigational study of the liquid biomarker microRNA 371a-3p in newly diagnosed germ cell tumours—Real-world trial design, rapid accrual, and robust secondary use of data opportunities.
Authors
Antoine Morin Coulombe
BCCancer, Vancouver, BC, Canada
Antoine Morin Coulombe , Guliz Ozgun , Rebecca Johnson , Mark Andrew Lewis , Nabil Adra , Scott E. Eggener , Bruce J. Roth , Christopher W. Ryan , Christopher Porter , Fred Millard , Thomas Jang , Robert James Hamilton , Lawrence H. Einhorn , Christian K. Kollmannsberger , Kathryn B. Arnold , Charles David Blanke , Siamak Daneshmand , Craig R. Nichols , Lucia Nappi , Andrea Harzstark
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Clinical Trial Registration Number
NCT03067181
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS5103)
DOI
10.1200/JCO.2023.41.16_suppl.TPS5103
Abstract #
TPS5103
Poster Bd #
194b
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT).
First Author: Darren R. Feldman
Poster
2019 ASCO Annual Meeting
DGM1 may serve as a novel genetic biomarker of response to enzastaurin in glioblastoma.
First Author: Nicholas A. Butowski
Poster
2013 ASCO Annual Meeting
Rapid online feedback to improve clinical trial accrual: CODEL anaplastic glioma (AG) (NCCTG/Alliance N0577) as a model.
First Author: Holly Massett
Poster
2024 ASCO Genitourinary Cancers Symposium
Identification of a panel of microRNA biomarkers for the management of patients with refractory germ cell tumor of the testis.
First Author: Jim Zhongning Chen